Testolactone
Back to searchMolecule Structure
Scientific Name
Testolactone
Description of the Drug
Testolactone is a medication used to treat advanced breast cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00894
http://www.drugbank.ca/drugs/DB00894
Brand Name(s)
Fludestrin, Teslac
Company Owner(s)
Bristol Myers Squibb Co, Bristol Myers Squibb
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytochrome P450 19A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1978 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4053 |
| PharmGKB | PA164743056 |
| Human Metabolome Database | HMDB0015031 |
| DrugBank | DB00894 |
| PubChem: Thomson Pharma | 16241793 |
| PubChem | 13769 |
| Nikkaji | J7.201J |
| BindingDB | 50367848 |
| EPA CompTox Dashboard | DTXSID2023644 |
| LipidMaps | LMST02020084 |
| DrugCentral | 2606 |
| Brenda | 71487 |
| ChemicalBook | CB4371689 |
| Guide to Pharmacology | 7303 |
| rxnorm | TESTOLACTONE |
| PubChem: Drugs of the Future | 136349969 |
| KEGG Ligand | C02197 |
| ChEBI | 9460 |
| ZINC | ZINC000004081771 |
